{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T12:30:10Z","timestamp":1785933010778,"version":"3.56.0"},"reference-count":39,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Grant-in-Aid for Research Activity start-up","doi-asserted-by":"publisher","award":["19K21225"],"award-info":[{"award-number":["19K21225"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Grant-in-Aid for Research Activity start-up","doi-asserted-by":"publisher","award":["20K18476"],"award-info":[{"award-number":["20K18476"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Grant-in-Aid for Early-Career Scientists","doi-asserted-by":"publisher","award":["19K21225"],"award-info":[{"award-number":["19K21225"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Grant-in-Aid for Early-Career Scientists","doi-asserted-by":"publisher","award":["20K18476"],"award-info":[{"award-number":["20K18476"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Post-traumatic trigeminal neuropathy (PTTN) is a sensory abnormality caused by injury to the trigeminal nerve during orofacial surgery. However, existing analgesics are ineffective against PTTN. Abnormal microglial activation in the caudal part of the spinal trigeminal nucleus caudal part (Sp5C), where the central trigeminal nerve terminals reside, plays an important role in PTTN pathogenesis. Therefore, regulating microglial activity in Sp5C appears to be an important approach to controlling pain in PTTN. Cannabinoid receptor 2 (CB2) is expressed in immune cells including microglia, and its activation has anti-inflammatory effects. The current study demonstrates that the repeated intranasal administration of CB2 agonist HU-308 ameliorates the infraorbital nerve cut (IONC)-induced hyperresponsiveness to acetone (cutaneous cooling). The therapeutic efficacy of oral HU-308 was found to be less pronounced in alleviating cold hypersensitivity in IONC mice compared to intranasal administration, indicating the potential advantages of the intranasal route. Furthermore, repeated intranasal administration of HU-308 suppressed the activation of Sp5C microglia in IONC mice. Additionally, pretreatment with the CB2 antagonist, SR 144528, significantly blocked the anti-nociceptive effect of repeated intranasal administration of HU-308 on cold hypersensitization in IONC mice. These data suggest that the continuous stimulation of CB2 ameliorates PTTN-induced pain via the inhibition of microglial activation. Thus, CB2 agonists are potential candidates for novel therapeutic agents against PTTN.<\/jats:p>","DOI":"10.3390\/cells13231943","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T12:07:32Z","timestamp":1732277252000},"page":"1943","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intranasal Treatment with Cannabinoid 2 Receptor Agonist HU-308 Ameliorates Cold Sensitivity in Mice with Traumatic Trigeminal Neuropathic Pain"],"prefix":"10.3390","volume":"13","author":[{"given":"Simeng","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9226-676X","authenticated-orcid":false,"given":"Yoki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzuna","family":"Uemoto","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazue","family":"Hisaoka-Nakashima","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9148-4167","authenticated-orcid":false,"given":"Norimitsu","family":"Morioka","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","article-title":"Chronic pain: An update on burden, best practices, and new advances","volume":"397","author":"Cohen","year":"2021","journal-title":"Lancet"},{"key":"ref_2","first-page":"CD006146","article-title":"Opioids for neuropathic pain","volume":"8","author":"McNicol","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ca.22330","article-title":"Microsurgical anatomy of the trigeminal nerve","volume":"27","author":"Joo","year":"2014","journal-title":"Clin. Anat."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1097\/j.pain.0000000000000265","article-title":"Altered pain modulation in patients with persistent postendodontic pain","volume":"156","author":"Khan","year":"2015","journal-title":"Pain"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jpain.2015.05.011","article-title":"Long-Term Outcome of the Management of Chronic Neuropathic Pain: A Prospective Observational Study","volume":"16","author":"Moulin","year":"2015","journal-title":"J. Pain"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1093\/pm\/pnz075","article-title":"A Comprehensive Algorithm for Management of Neuropathic Pain","volume":"20","author":"Bates","year":"2019","journal-title":"Pain Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"101301","DOI":"10.1016\/j.isci.2020.101301","article-title":"Cannabinoids and Cannabinoid Receptors: The Story so Far","volume":"23","author":"Shahbazi","year":"2020","journal-title":"iScience"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.tips.2020.06.010","article-title":"Structural and Functional Insights into Cannabinoid Receptors","volume":"41","author":"Li","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/s41467-023-37112-9","article-title":"Structural basis of selective cannabinoid CB","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_12","first-page":"199","article-title":"Pain-resolving immune mechanisms in neuropathic pain","volume":"19","author":"Fiore","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Nakamura, Y., Morioka, N., Abe, H., Zhang, F.F., Hisaoka-Nakashima, K., Liu, K., Nishibori, M., and Nakata, Y. (2013). Neuropathic pain in rats with a partial sciatic nerve ligation is alleviated by intravenous injection of monoclonal antibody to high mobility group box-1. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073640"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nrn.2018.2","article-title":"Microglia in neuropathic pain: Cellular and molecular mechanisms and therapeutic potential","volume":"19","author":"Inoue","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.neuron.2018.11.009","article-title":"Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain","volume":"100","author":"Chen","year":"2018","journal-title":"Neuron"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Nakamura, Y., Fukuta, A., Miyashita, K., Zhang, F.F., Wang, D., Liu, K., Wake, H., Hisaoka-Nakashima, K., Nishibori, M., and Morioka, N. (2021). Perineural high-mobility group box 1 induces mechanical hypersensitivity through activation of spinal microglia: Involvement of glutamate-NMDA receptor dependent mechanism in spinal dorsal horn. Biochem. Pharmacol., 186.","DOI":"10.1016\/j.bcp.2021.114496"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kochi, T., Nakamura, Y., Ma, S., Hisaoka-Nakashima, K., Wang, D., Liu, K., Wake, H., Nishibori, M., Irifune, M., and Morioka, N. (2021). Pretreatment with High Mobility Group Box-1 Monoclonal Antibody Prevents the Onset of Trigeminal Neuropathy in Mice with a Distal Infraorbital Nerve Chronic Constriction Injury. Molecules, 26.","DOI":"10.3390\/molecules26072035"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1248\/bpb.b23-00729","article-title":"Perineural Treatment with High Mobility Group Box-1 Monoclonal Antibody Prevents Initiation of Pain-Like Behaviors in Female Mice with Trigeminal Neuropathy","volume":"47","author":"Ma","year":"2024","journal-title":"Biol. Pharm. Bull."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","article-title":"Evaluation of intranasal delivery route of drug administration for brain targeting","volume":"143","author":"Bors","year":"2018","journal-title":"Brain Res. Bull."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jconrel.2018.08.006","article-title":"Delivery of immunoglobulin G antibodies to the rat nervous system following intranasal administration: Distribution, dose-response, and mechanisms of delivery","volume":"286","author":"Kumar","year":"2018","journal-title":"J. Control Release"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Sato, F., Nakamura, Y., Ma, S., Kochi, T., Hisaoka-Nakashima, K., Wang, D., Liu, K., Wake, H., Nishibori, M., and Morioka, N. (2022). Central high mobility group box-1 induces mechanical hypersensitivity with spinal microglial activation in a mouse model of hemi-Parkinson\u2019s disease. Biomed. Pharmacother., 145.","DOI":"10.1016\/j.biopha.2021.112479"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"108823","DOI":"10.1016\/j.celrep.2021.108823","article-title":"Brainstem local microglia induce whisker map plasticity in the thalamus after peripheral nerve injury","volume":"34","author":"Ueta","year":"2021","journal-title":"Cell Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/brain\/aww038","article-title":"TRPA1 mediates trigeminal neuropathic pain in mice downstream of monocytes\/macrophages and oxidative stress","volume":"139","author":"Trevisan","year":"2016","journal-title":"Brain"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e2200057120","DOI":"10.1073\/pnas.2200057120","article-title":"Intranasal delivery of full-length anti-Nogo-A antibody: A potential alternative route for therapeutic antibodies to central nervous system targets","volume":"120","author":"Correa","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"14228","DOI":"10.1073\/pnas.96.25.14228","article-title":"HU-308: A specific agonist for CB(2), a peripheral cannabinoid receptor","volume":"96","author":"Hanus","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s12974-020-02003-z","article-title":"Microglial responses to peripheral type 1 interferon","volume":"17","author":"Aw","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Stirling, D.R., Swain-Bowden, M.J., Lucas, A.M., Carpenter, A.E., Cimini, B.A., and Goodman, A. (2021). CellProfiler 4: Improvements in speed, utility and usability. BMC Bioinform., 22.","DOI":"10.1186\/s12859-021-04344-9"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/bja\/aet125","article-title":"Differential diagnosis of facial pain and guidelines for management","volume":"111","author":"Zakrzewska","year":"2013","journal-title":"Br. J. Anaesth."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.bjp.0707584","article-title":"CB2 receptors in the brain: Role in central immune function","volume":"153","author":"Cabral","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_30","first-page":"25","article-title":"Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation","volume":"5","author":"Horvath","year":"2009","journal-title":"Mol. Pain."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-2-29","article-title":"Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation","volume":"2","author":"Ehrhart","year":"2005","journal-title":"J. Neuroinflamm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer\u2019s disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation","volume":"25","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbi.2015.06.002","article-title":"Endocannabinoids drive the acquisition of an alternative phenotype in microglia","volume":"49","author":"Mecha","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Komorowska-M\u00fcller, J.A., and Schm\u00f6le, A.C. (2020). CB2 Receptor in Microglia: The Guardian of Self-Control. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010019"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Sa\u0142at, K., Furga\u0142a-Wojas, A., and Sa\u0142at, R. (2021). The Microglial Activation Inhibitor Minocycline, Used Alone and in Combination with Duloxetine, Attenuates Pain Caused by Oxaliplatin in Mice. Molecules, 26.","DOI":"10.3390\/molecules26123577"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"13958","DOI":"10.1038\/ncomms13958","article-title":"Cannabinoid CB","volume":"8","author":"Soethoudt","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12974-017-1022-3","article-title":"Macrophages in trigeminal ganglion contribute to ectopic mechanical hypersensitivity following inferior alveolar nerve injury in rats","volume":"14","author":"Batbold","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/sj.bjp.0707569","article-title":"CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration","volume":"153","author":"Rajesh","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.bjp.0707486","article-title":"Cannabinoid CB2 receptors in the gastrointestinal tract: A regulatory system in states of inflammation","volume":"153","author":"Wright","year":"2008","journal-title":"Br. J. Pharmacol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/23\/1943\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:37:55Z","timestamp":1760114275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/23\/1943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":39,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["cells13231943"],"URL":"https:\/\/doi.org\/10.3390\/cells13231943","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]}}}